Turnstone Biologics Corp. Common Stock
Turnstone Biologics Corp. operates as a biotechnology company. The company was founded in 2014 and is headquartered in San Diego, California. As of August 11, 2025, Turnstone Biologics Corp. operates as a subsidiary of XOMA Royalty Corporation.
Market Cap & Net Worth: Turnstone Biologics Corp. Common Stock (TSBX)
Turnstone Biologics Corp. Common Stock (NASDAQ:TSBX) has a market capitalization of $8.21 Million ($8.21 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31246 globally and #10285 in its home market, demonstrating a 1.37% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Turnstone Biologics Corp. Common Stock's stock price $0.36 by its total outstanding shares 23140700 (23.14 Million).
Turnstone Biologics Corp. Common Stock Market Cap History: 2023 to 2025
Turnstone Biologics Corp. Common Stock's market capitalization history from 2023 to 2025. Data shows change from $58.89 Million to $8.21 Million (-81.85% CAGR).
Index Memberships
Turnstone Biologics Corp. Common Stock is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.20 Trillion | 0.00% | #802 of 976 |
|
NASDAQ Composite
IXIC
|
$32.97 Trillion | 0.00% | #2544 of 3165 |
Weight: Turnstone Biologics Corp. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Turnstone Biologics Corp. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Turnstone Biologics Corp. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.05x
Turnstone Biologics Corp. Common Stock's market cap is 3.05 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $58.89 Million | $19.31 Million | -$55.20 Million | 3.05x | N/A |
Competitor Companies of TSBX by Market Capitalization
Companies near Turnstone Biologics Corp. Common Stock in the global market cap rankings as of March 19, 2026.
Key companies related to Turnstone Biologics Corp. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Turnstone Biologics Corp. Common Stock Historical Marketcap From 2023 to 2025
Between 2023 and today, Turnstone Biologics Corp. Common Stock's market cap moved from $58.89 Million to $ 8.21 Million, with a yearly change of -81.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.21 Million | -28.56% |
| 2024 | $11.50 Million | -80.48% |
| 2023 | $58.89 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Turnstone Biologics Corp. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.21 Million USD |
| MoneyControl | $8.21 Million USD |
| MarketWatch | $8.21 Million USD |
| marketcap.company | $8.21 Million USD |
| Reuters | $8.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.